CM
Cesar Mauricio Jose De Menezes
About Cesar Mauricio Jose De Menezes
Data last updated:
Cesar Mauricio Jose De Menezes is a Managing Director at Wallace Pharmaceuticals Private Limited (since 2005), Director at Indi Pharma Private Limited (since 2006) and Designated Partner at Wallace Medipharma Llp (since 2020), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Research & Development. The 3 current companies with reported revenue have a combined latest revenue of ₹700 Cr; the largest is Wallace Pharmaceuticals Private Limited at ₹673 Cr (FY 2025). Earlier, Cesar Mauricio Jose De Menezes was a Director at Wallace Medipharma Private Limited (2002–2020) and Director at Goodwin Biotechnology India Private Limited (2006–2017) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wallace Pharmaceuticals Private Limited U24239GA1968PTC000080 | Managing Director | 15 Jun 2005 | 1968 | ₹673 Cr (FY 2025) | Active |
 Indi Pharma Private Limited U24232GA1984PTC000556 | Director | 15 Mar 2006 | 1984 | ₹26.28 Cr (FY 2024) | Active |
 Wallace Medipharma Llp AAS-0492 | Designated Partner | 26 Feb 2020 | 2020 | ₹19.2 Lakh (FY 2024) | Active |
| Wallace Medinova Llp AAR-9667 | Designated Partner | 18 Feb 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Wallace Medipharma Private Limited U24232GA1998PTC002526 | Director | 28 Jun 2002 | 1998 | ₹1.5 Lakh (FY 2019) | Converted To Llp |
| Goodwin Biotechnology India Private Limited U73100GA2006PTC004842 | Director | 20 Sep 2006 | 2006 | ₹45.5 Lakh (FY 2019) | Strike Off |
| Wallace Estates Private Limited U70200GA1996PTC002078 | Director | 21 Feb 2017 | 1996 | ₹28,886 (FY 2019) | Converted To Llp |
| Wallace Medinova Private Limited U52311GA1997PTC002273 | Director | 05 Feb 1997 | 1997 | ₹91,220 (FY 2019) | Converted To Llp |
| Wallace Estates Llp AAR-7944 | Designated Partner | 03 Feb 2020 | 2020 | Strike Off | |
| Wallace Laboratories Private Limited U33112GA1996PTC002077 | Director | 15 Mar 2006 | 1996 | ₹22.71 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Cesar Mauricio Jose De Menezes
| Name | DIN | Company | Designation |
|---|---|---|---|
| Maria Emilia Dias Menezes | 00419902 | Wallace Pharmaceuticals Private Limited , Indi Pharma Private Limited and 2 more | Director |
| Pankaj Kumar | 08761171 | Wallace Pharmaceuticals Private Limited | Director |
| Rajashekhar Rayanagoudar Basanagouda | 07525704 | Wallace Pharmaceuticals Private Limited | Whole-Time Director |
| Rashmi Menezes | 01006018 | Wallace Pharmaceuticals Private Limited | Managing Director |
| Sandeep Inamdar | 10935367 | Wallace Pharmaceuticals Private Limited | Whole-Time Director |
| Vinay Pinto | 01005975 | Wallace Pharmaceuticals Private Limited | Director |
| Antonio Xavier Paulo Fernandes | 00407426 | Indi Pharma Private Limited | Director |
| Ramakrishna Vasudev Bhat | 08581846 | Indi Pharma Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Cesar Mauricio Jose De Menezes
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cesar Mauricio Jose De Menezes
Cesar Mauricio Jose De Menezes currently holds 4 directorships: Wallace Pharmaceuticals Private Limited (Managing Director, since 15 Jun 2005, revenue ₹673 Cr (FY 2025)); Indi Pharma Private Limited (Director, since 15 Mar 2006, revenue ₹26.28 Cr (FY 2024)); Wallace Medipharma Llp (Designated Partner, since 26 Feb 2020, revenue ₹19.2 Lakh (FY 2024)); Wallace Medinova Llp (Designated Partner, since 18 Feb 2020).
Cesar Mauricio Jose De Menezes was first appointed on 05 Feb 1997 as Director at Wallace Medinova Private Limited. The most recent appointment on record is 26 Feb 2020 at Wallace Medipharma Llp.
The 3 current companies of Cesar Mauricio Jose De Menezes that report revenue have a combined latest revenue of ₹700 Cr: Wallace Pharmaceuticals Private Limited ₹673 Cr (FY 2025); Indi Pharma Private Limited ₹26.28 Cr (FY 2024); Wallace Medipharma Llp ₹19.2 Lakh (FY 2024).
Cesar Mauricio Jose De Menezes held 6 earlier board appointments: Wallace Medipharma Private Limited (Director, 28 Jun 2002 to 25 Feb 2020); Goodwin Biotechnology India Private Limited (Director, 20 Sep 2006 to 25 Jan 2017); Wallace Estates Private Limited (Director, 21 Feb 2017 to 02 Feb 2020); Wallace Medinova Private Limited (Director, 05 Feb 1997 to 17 Feb 2020); Wallace Estates Llp (Designated Partner, from 03 Feb 2020); and 1 more.
The current boards of Cesar Mauricio Jose De Menezes's companies include Maria Emilia Dias Menezes (Wallace Pharmaceuticals Private Limited), Pankaj Kumar (Wallace Pharmaceuticals Private Limited), Rajashekhar Rayanagoudar Basanagouda (Wallace Pharmaceuticals Private Limited), Rashmi Menezes (Wallace Pharmaceuticals Private Limited), Sandeep Inamdar (Wallace Pharmaceuticals Private Limited), Vinay Pinto (Wallace Pharmaceuticals Private Limited), among others.